Disabled, invisible and dismissed—The lived experience of fatigue in people with myeloproliferative neoplasms-Reference-Cited by-同舟云学术

Disabled, invisible and dismissed—The lived experience of fatigue in people with myeloproliferative neoplasms

Published:2022-06-15 Issue:1 Volume:6 Page:
ISSN:2573-8348
Container-title:Cancer Reports
language:en
Short-container-title:Cancer Reports

Author:

Bradford Ashleigh¹²,Young Ken³^ORCID,Whitechurch Ashley¹,Burbury Kate¹²,Pearson Elizabeth Jane M.¹²^ORCID

Affiliation:

1. Department of Health Services and Implementation Research | Department of Nursing | Department of Clinical Hematology Peter MacCallum Cancer Centre Melbourne Victoria Australia

2. Department of Clinical Pathology | The Sir Peter MacCallum Department of Oncology The University of Melbourne Melbourne Victoria Australia

3. MPN Alliance Australia Sandringham Victoria Australia

Funder

Victorian Cancer Agency

Peter MacCallum Cancer Centre

Department of Health Services

Publisher

Wiley

Subject

Cancer Research,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cnr2.1655

Reference36 articles.

1. Classification and diagnosis of myeloproliferative neoplasms according to the 2008 World Health Organization criteria

2. Comprehensively understanding fatigue in patients with myeloproliferative neoplasms

3. Myeloproliferative neoplasms (MPNs) have a significant impact on patients’ overall health and productivity: the MPN Landmark survey

4. Diagnosis, risk stratification, and response evaluation in classical myeloproliferative neoplasms

5. JAK-STAT signaling in the therapeutic landscape of myeloproliferative neoplasms

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Top Ten Tips Palliative Care Clinicians Should Know About Caring for Patients with Myeloproliferative Neoplasms;Journal of Palliative Medicine;2024-08-20

2. The psychological needs of adolescents and young adults with a diagnosis of myeloproliferative neoplasms: a systematic scoping review of the literature;Leukemia & Lymphoma;2024-02-07